De Backer G, Ambrosioni E, Borch-Johnsen, et al. 2003. European guide- lines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J, 24:1601–10. Evans A, Tolonen H, Hense HW, et al. 2001. Trends in coronary risk factors in the WHO MONICA project. Int J Epidemiol, 30 (Suppl 1):35–40. [HPSCG] Heart Protection Collaborative Group. 2002. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet, 360:7–22. Law MR, Wald NJ. 1994. An ecological study of serum cholesterol and ischaemic heart disease between 1950 and 1990. Eur J Clin Nutr, 48:305–25. Law MR, Wald NJ, Thompson SG. 1994a. By how much and how quickly does reduction in serum cholesterol concentration lower risk of isch- aemic heart disease? BMJ, 308:367–72. Law MR, Wald NJ, Wu T, et al. 1994b. Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study. BMJ, 308:363–6. Levy RI, Brensike, JF, Epstein SE, et al. 1984. The inﬂuence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Interven- tion Study. Circulation, 69:325–37. Secular trends in lipids after AMI Pekkanen J, Linn S, Heiss G, et al. 1990. Ten-year mortality from cardiovas- cular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med, 322:1700–7. Sharrett AR, Ballantyne, CM, Coady SA, et al. 2001. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfrac- tions: The Atherosclerosis Risk in Communities (ARIC) Study. Cir- culation, 104:1108–13. Shekelle RB, Shyrock AM, Paul O, et al. 1981. Diet, serum cholesterol, and death from coronary heart disease. The Western Electric study. N Engl J Med, 304:65–70. Watts GF, Lewis B, Brunt, J N, Lewis, ES, et al. 1992. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas’ Atherosclerosis Regression Study (STARS). Lancet, 339:563–9. Wilhelmsen L, Johansson S, Rosengren A, et al. 1997. Risk factors for car- diovascular disease during the period 1985–1995 in Goteborg, Sweden. The GOT-MONICA Project. J Intern Med, 242:199–211. Vascular Health and Risk Management 2007:3(6) 1051